How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test reveals genetic predispositions in key peptide and cardiovascular pathwaysincluding variants in the GIPR genesthat may help provide context for how your body responds to GLP-1 therapy
Harrison SA, Browne SK, Suschak JJ, et al
J., Qiu, Y., Kido, T
Singapore: Imperial College Press, Print
However, local concentration gradients may favor tissues nearest the injection point, at least initially after administration
Dougados M, Wei JC, Landewe R et al (2020) Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)